Dhul Qadah 29 is the last day for Umrah pilgrims to leave the Kingdom 90-day duration of visa begins from the date of entering the Kingdom; Hajj Ministry clarifies    Centuries-old defensive moat and fortification wall unearthed in Historic Jeddah    7,700 commercial disputes resolved via Taradhi platform, says Ministry of Justice    'Saudi hospitality sector to generate SR42 billion investments and 120,000 jobs by 2030'    Chinese workers disagree with West over mass production claims    IMF forecast: Saudi economy to record 2nd highest global growth rate in 2025    EU's Josep Borrell warns Middle East 'on edge of regional war'    Indonesia issues tsunami alert after volcano erupts on remote island    US Senate kills the articles of impeachment against Alejandro Mayorkas    Dubai airport reopens after UAE suffers heavy rain    Poignant shot from Gaza wins World Press Photo of the Year 2024    NEOM launches 'Discover NEOM' China showcase with top industry leaders    Al Ain ends Al Hilal's record streak with a 4-2 win in AFC Champions League semi-final    Saudi Pro League postpones Al-Hilal vs. Al-Ahli match; Al-Ahli rejects rescheduling    50% traffic fine reduction takes effect    'Zarqa Al Yamama': Tickets now available for Saudi Arabia's first opera premiering April 25    AFC postpones Al Ain vs Al Hilal semi-final match due to weather conditions    Turki Alalshikh announces groundbreaking 5 vs 5 Riyadh Season bout featuring international boxing stars    Diriyah Biennale Foundation announces shortlist for AlMusalla Prize, set to revolutionize musalla architecture    Fourth Gulf Film Festival kicks off in Riyadh, scaling up Saudi movie industry Event extends over 5 days with the screening of 29 diverse films    JK Rowling in 'arrest me' challenge over hate crime law    Trump's Bible endorsement raises concern in Christian religious circles    Hollywood icon Will Smith shares his profound admiration for Holy Qur'an    We have celebrated Founding Day for three years - but it has been with us for 300    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



One shot or two? Many questions unresolved in Ebola vaccine race
Published in The Saudi Gazette on 13 - 12 - 2014

SCIENTISTS racing to develop vaccines against Ebola are trying to determine whether they can best fight the disease with a single injection or with two, a calculation that could determine how quickly and effectively a program can be rolled out.
Administering two vaccines, one after the other, would almost certainly give far greater protection than a single shot against a deadly virus that has killed more than 6,000 people in West Africa this year.
But it would also make mass immunizations far more complicated in the worst-affected countries of Guinea, Liberia and Sierra Leone, where weak health systems have all but collapsed under the weight of the epidemic.
With the epidemic growing exponentially through much of 2014, the initial focus was on developing a single shot that could be tested and deployed as fast as possible.
Now, however, with disease transmission rates tailing off markedly in Liberia, there is more debate about a double vaccine program that would provide greater protection, even if it might take longer and be harder to implement.
“There is now more and more talk about what can we do to prolong vaccine protection,” said Ripley Ballou, head of Ebola research at GlaxoSmithKline, which has one of the leading vaccine candidates.
He still hopes a single-dose vaccine will be of use in the current outbreak, but also sees a need to evaluate the “prime-boost” approach of giving a first shot to stimulate the immune system, followed by a second booster a few weeks later.
Health officials in London and Washington, as well as non-profit groups like the Wellcome Trust that are also helping fund clinical trials, are liaising closely on the best way forward.
“We're trying to decide where it is best to put the money,” said one senior government adviser.
A big Liberia trial, involving up to 30,000 participants, will test single shots of GSK's vaccine, a rival one from NewLink and Merck, and a placebo.
Although the Ebola slowdown in Liberia is clearly good news, it means the trial may not see enough new cases of disease to demonstrate the benefit of vaccination.
Production capacity
Other studies are starting to analyze the prime-boost approach. Johnson & Johnson expects to start testing its experimental shot with a booster developed by Denmark's Bavarian Nordic “very soon” and its chief scientific officer, Paul Stoffels, is convinced this is the right strategy.
“It is cumbersome, because you need two vaccines, but it is clear that you will get the best protection, both short and long term, from a prime-boost,” he said.
A prime-boost vaccine will be more difficult to make in large quantities, since the booster component from Bavarian needs to be grown in chicken eggs, limiting supply. But past experience suggests it should pack more punch.
Tests of similar two-pronged vaccines in other diseases suggest the booster component can increase immune responses around 30-fold for the production of antibodies and up to 10-fold for the body's own disease-fighting T-cells — two of the key elements of the ability to fight off infection — said Adrian Hill, a vaccine expert at Oxford University's Jenner Institute.
That extra protection may be needed in West Africa, where infection with malaria could also depress people's immune systems, limiting the effectiveness of immunization.
In the end, the wide program of vaccine trials scheduled for the first half of 2015 may yield a variety of options, with some experts suggesting prime-boost may be particularly suited for healthcare workers facing regular high exposure and single shots the preferred choice for rapid containment of local cases.
So far, the only human data on how well Ebola vaccines might work comes from the United States and Europe, with GSK's shot proving safe and showing some efficacy, although not comprehensive protection. NewLink's experimental shot had no serious side effects but caused some mild fever.
With the epidemic still raging, tests are likely to try out combinations of vaccines in an opportunistic way. While their impact may not become clear until later next year, the lessons learned will still be valuable in responding to the next, inevitable, Ebola outbreak.
“This disease is going to be endemic in West Africa,” said GSK's Ballou. “It's important for those countries either to have routine vaccination or a stockpile option.” — Reuters


Clic here to read the story from its source.